Literature DB >> 1535450

Over-estimation of the number of complement receptor type 1 (CR1) on erythrocytes.

R A Quadri1, J A Schifferli.   

Abstract

The number of CR1 on erythrocytes, as measured by monoclonal antibodies, remains undefined because of the repetitive structure of CR1 and the presence of different types of structural CR1 alleles. We studied the number of CR1 per erythrocyte using two monoclonal antibodies, E11 and 3D9, which recognize different sites on CR1. The number of binding sites was higher for E11 than for 3D9 (ratio E11/3D9: 1.9 +/- 0.4, n = 17); however, this ratio was not affected by CR1 numbers or alleles. Partial digestion with papain of CR1 on erythrocytes abolished the binding of 3D9. It reduced the binding of E11 to one-third of its initial value (0.35 +/- 0.03; n = 13) using cells with different CR1 numbers or alleles. By immunoblotting, a unique 75-kDa stump of CR1 remained attached to the erythrocytes for every allele studied. Taken together, these results suggest that the number of CR1 has been over-estimated in the past using E11 by a factor of 2, or more probably 3. However, the over-estimation of CR1 number has been identical for erythrocytes bearing different CR1 numbers or alleles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535450     DOI: 10.1111/j.1365-3083.1992.tb02948.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Mapping epitopes for 20 monoclonal antibodies to CR1.

Authors:  M Nickells; R Hauhart; M Krych; V B Subramanian; K Geoghegan-Barek; H C Marsh; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

2.  Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.

Authors:  Boudewijn Klop; Pieter van der Pol; Robin van Bruggen; Yanan Wang; Marijke A de Vries; Selvetta van Santen; Joseph O'Flynn; Gert-Jan M van de Geijn; Tjin L Njo; Hans W Janssen; Peter de Man; J Wouter Jukema; Ton J Rabelink; Patrick C N Rensen; Cees van Kooten; Manuel Castro Cabezas
Journal:  J Biol Chem       Date:  2014-10-27       Impact factor: 5.157

Review 3.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.

Authors:  J Miyaike; Y Iwasaki; A Takahashi; H Shimomura; H Taniguchi; N Koide; K Matsuura; T Ogura; K Tobe; T Tsuji
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

5.  Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.

Authors:  D Di Bona; G Montalto; L Clemenza; F Bascone; P Accardo; D Bellavia; A Craxì; M Brai
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

6.  Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes.

Authors:  M Pascual; G Steiger; S Sadallah; J P Paccaud; J L Carpentier; R James; J A Schifferli
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

7.  Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Authors:  D H Opi; S Uyoga; E N Orori; T N Williams; J A Rowe
Journal:  Genes Immun       Date:  2016-02-04       Impact factor: 2.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.